GSA CAPITAL PARTNERS LLP - BIOSPECIFICS TECHNOLOGIES CO ownership

Back to all holdings Add to watchlist

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 94 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q1 2020$287,000
-35.2%
5,081
-34.6%
0.07%
+38.5%
Q4 2019$443,000
-22.7%
7,773
-19.0%
0.05%
-18.8%
Q2 2019$573,000
-20.1%
9,600
-16.5%
0.06%
-12.3%
Q1 2019$717,000
+62.2%
11,500
+57.5%
0.07%
+43.1%
Q4 2018$442,000
+3.5%
7,3000.0%0.05%
+112.5%
Q3 2018$427,000
+0.2%
7,300
-23.2%
0.02%
+14.3%
Q2 2018$426,000
+91.9%
9,500
+89.7%
0.02%
+75.0%
Q1 2018$222,000
-28.8%
5,009
-30.5%
0.01%
-36.8%
Q4 2017$312,000
-20.2%
7,209
-14.3%
0.02%
-29.6%
Q3 2017$391,000
-28.3%
8,409
-23.6%
0.03%
-25.0%
Q2 2017$545,000
-69.7%
11,009
-66.5%
0.04%
-62.9%
Q1 2017$1,800,000
-25.4%
32,847
-24.2%
0.10%
-32.6%
Q4 2016$2,414,000
+5.4%
43,347
-13.6%
0.14%
+17.1%
Q3 2016$2,290,000
+31.7%
50,147
+15.2%
0.12%
+28.1%
Q2 2016$1,739,000
-44.4%
43,547
-51.5%
0.10%
-51.8%
Q1 2016$3,125,000
-20.4%
89,747
-1.8%
0.20%
+3.6%
Q4 2015$3,925,000
+32.9%
91,347
+34.6%
0.19%
+32.4%
Q3 2015$2,954,000
-4.2%
67,847
+13.6%
0.14%
+22.9%
Q2 2015$3,083,000
+23.7%
59,747
-6.1%
0.12%
+19.2%
Q1 2015$2,492,000
+19.8%
63,647
+18.2%
0.10%
-31.7%
Q4 2014$2,080,000
+29.7%
53,847
+18.5%
0.14%
+72.6%
Q3 2014$1,604,000
+18.9%
45,447
-9.2%
0.08%
+37.7%
Q2 2014$1,349,000
+54.7%
50,047
+48.7%
0.06%
-1.6%
Q1 2014$872,000
+43.0%
33,647
+19.5%
0.06%
+29.2%
Q4 2013$610,000
+118.6%
28,147
+96.3%
0.05%
+118.2%
Q3 2013$279,000–14,338–0.02%–
 Download
Other shareholders

There were no reported owners of BIOSPECIFICS TECHNOLOGIES CO in Q3 2018.

NameSharesValueWeighting ↓
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders